BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 19, 2021
View Archived Issues
HER2 CAR-NK cells show preclinical antitumor activity without off-target cytotoxicity
Read More
TGF-beta-mediated mTOR inhibition preserves cellular metabolism of precursors of exhausted T cells
Read More
New prosthetic valvular graft infection model shows benefit of adjunctive fibrinolytic treatment
Read More
Model of steroid-resistant neutrophilic asthma developed to test treatments
Read More
GFAP a biomarker in frontotemporal lobar degeneration and primary psychiatric disorders
Read More
TYK Medicines divulges new Ret inhibitors
Read More
Wigen Biomedicine Technology presents KRAS mutant inhibitors
Read More
FDA accepts IND application for phase IIa study of Quilience as treatment of narcolepsy
Read More
UCB discloses new FCER1A mutant inhibitors
Read More
FDA clears IND for phase I trial of SYSA-1801 in advanced pancreatic cancer
Read More
Phase I trial investigates SHJ-002 for myopia in pediatric subjects
Read More
ABBV-CLS-7262 studied in phase I for ALS
Read More
BIX-119 leads to improved clinical benefit through blocking both IL-17 and IL-22
Read More
Scioto opens phase I study of SB-121 in participants with autistic disorder
Read More
New neonatal murine model of Listeria monocytogenes meningitis developed
Read More
Clarity recruits patients with prostate cancer to evaluate PET imaging with [64Cu]SAR-bisPSMA
Read More
Discovery of novel selective Axl inhibitor with antitumor activity in vivo
Read More
Phase II/III trial studies SHR-1701 with BP-102 and XELOX in first-line metastatic colorectal cancer
Read More
U.S. phase II trial explores use of Velexbru in primary central nervous system lymphoma
Read More
CytoDyn reports preliminary data on leronlimab in metastatic TNBC
Read More